Recombinant Human FBXL2 protein (GST tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human FBXL2 protein (GST tag N-Terminus) is a Human Full Length protein, in the 1 to 423 aa range, expressed in Wheat germ, suitable for ELISA, WB.
View Alternative Names
FBL2, FBL3, FBXL2, F-box/LRR-repeat protein 2, F-box and leucine-rich repeat protein 2, F-box protein FBL2/FBL3
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human FBXL2 protein (GST tag N-Terminus) (AB161801)
ab161801 on a 12.5% SDS-PAGE stained with Coomassie Blue.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The FBXL2 protein maintains cellular protein quality by regulating the turnover of specific substrates. It forms a complex with SKP1 and Cullin-2 in the ubiquitin-proteasome pathway. FBXL2 mediates the degradation of important regulatory proteins influencing the cell cycle and signal transduction. This activity impacts cellular responses to stress and environmental changes ensuring proper cellular adaptation.
Pathways
FBXL2 participates in the cell cycle and apoptosis regulation pathways. It intersects with the PI3K/Akt signaling pathway where it interacts with proteins like Cyclin D1 and Cdk inhibitors playing a part in cell proliferation and survival. These interactions demonstrate FBXL2's important role in controlling cell growth and division affecting how cells respond to intrinsic and extrinsic signals.
Specifications
Form
Liquid
General info
Function
Calcium-activated substrate recognition component of the SCF (SKP1-cullin-F-box protein) E3 ubiquitin-protein ligase complex, SCF(FBXL2), which mediates the ubiquitination and subsequent proteasomal degradation of target proteins (PubMed : 22020328, PubMed : 22323446, PubMed : 31209342). Unlike many F-box proteins, FBXL2 does not seem to target phosphodegron within its substrates but rather calmodulin-binding motifs and is thereby antagonized by calmodulin (PubMed : 22020328, PubMed : 22323446). This is the case for the cyclins CCND2 and CCND3 which polyubiquitination and subsequent degradation are inhibited by calmodulin (PubMed : 22020328, PubMed : 22323446). Through CCND2 and CCND3 degradation induces cell-cycle arrest in G(0) (PubMed : 22020328, PubMed : 22323446). SCF(FBXL2) also mediates PIK3R2 ubiquitination and proteasomal degradation thereby regulating phosphatidylinositol 3-kinase signaling and autophagy (PubMed : 23604317). PCYT1A monoubiquitination by SCF(FBXL2) and subsequent degradation regulates synthesis of phosphatidylcholine, which is utilized for formation of membranes and of pulmonary surfactant (By similarity). The SCF(FBXL2) complex acts as a regulator of inflammation by mediating ubiquitination and degradation of TRAF proteins (TRAF1, TRAF2, TRAF3, TRAF4, TRAF5 and TRAF6) (By similarity). The SCF(FBXL2) complex acts as a negative regulator of the NLRP3 inflammasome by mediating ubiquitination and degradation of NLRP3 (PubMed : 26037928). The GGTase-3 complex, composed of PTAR1 and RABGGTB, geranylgeranylates and targets FBXL2 to the cellular membranes, where FBXL2 forms part of the SCF(FBXL2) complex that mediates the degradation of membrane-anchored proteins (PubMed : 31209342, PubMed : 32128853).
Post-translational modifications
Phosphorylated by GSK-beta (GSK3B), promoting recognition by FBXO3, leading to its ubiquitination by the SCF(FBXO3) complex.. Ubiquitinated at Lys-201 by the SCF(FBXO3) complex in response to lipopolysaccharide (LPS), leading to its degradation by the proteasome.. Geranylgeranylation at Cys-420 is mediated by the GGTase-3 complex and is required for its association with cell membranes and the recruitment of substrates to the active SCF(FBXL2) complex.
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com